Overview
Ravindra Veeranna practices practicing medicine in Mysore, India.
His clinical expertise encompasses Brucellosis, COVID-19, and Severe Acute Respiratory Syndrome (SARS).
He is actively involved in clinical research, co-authoring 16 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ravindra P. Veeranna
Is Ravindra P. Veeranna a top-rated expert for Brucellosis?
MediFind is an objective health platform that identifies experts based on real-world data. Ravindra P. Veeranna is classified as an Experienced expert for Brucellosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ravindra P. Veeranna participate in research or clinical trials?
Yes. Ravindra P. Veeranna has published 16 articles and abstracts on conditions like Brucellosis. You can view a list of Ravindra P. Veeranna's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- BrucellosisMr. Veeranna isExperienced. Learn about Brucellosis.
- COVID-19Mr. Veeranna isExperienced. Learn about COVID-19.
- Severe Acute Respiratory Syndrome (SARS)Mr. Veeranna isExperienced. Learn about Severe Acute Respiratory Syndrome (SARS).